查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095299

治療性呼吸設備市場－全球市場預測（2026-2032年）

Therapeutic Respiratory Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，呼吸治療市場將成長至 380.3 億美元，複合年成長率為 5.41%。

主要市場統計數據
基準年 2025 262.9億美元
預計年份：2026年 276.2億美元
預測年份 2032 380.3億美元
複合年成長率 (%) 5.41%

醫用呼吸器在現代醫療保健系統中扮演著核心角色，用於應對慢性阻塞性肺病（COPD）、氣喘、睡眠呼吸障礙、新生兒呼吸窘迫症候群、急性呼吸衰竭以及急性後期復健等疾病帶來的持續負擔。此類別包括氧氣療法系統、霧化器、正壓正壓呼吸器、人工呼吸器、加濕器、吸入治療裝置、呼吸道清潔系統以及輔助介面，廣泛應用於醫院、居家照護、急診和長期護理機構。人口老化、許多地區空氣污染和菸草煙霧暴露嚴重、阻塞型睡眠呼吸中止症中止症候群診斷數量增加以及家庭呼吸護理的廣泛普及，都推動了呼吸機需求的成長。

治療性呼吸設備的經營團隊前景主要由三個優先事項決定：臨床療效、護理連續性和安全易用性。儘管醫院仍依賴先進的呼吸支持和呼吸設備來救治重症患者，但隨著患者、保險公司和臨床醫生對慢性呼吸系統疾病管理負擔的減輕，居家照護的部署正在擴大。監管機構越來越關注醫療設備的安全性、網路安全、生物相容性、性能測試和上市後監測，這使得證據生成和品管系統成為至關重要的差異化因素。在此背景下，製造商和醫療保健提供者正在將醫療設備創新與數位化監測、患者依從性支援、感染預防以及與電子健康記錄和遠距醫療平台的互通性結合。

治療性呼吸系統市場發生變革性變化

在呼吸治療設備領域，正經歷結構性轉變，從間歇性的、以醫療機構為中心的治療模式轉變為連網的、長期的呼吸照護模式。居家氧氣療法、持續性陽壓呼吸器療法、攜帶式霧化器、氣道清理和非侵入性通氣等治療手段正日益融入慢性病管理方案中。這一轉變得益於設備便攜性的提升、電機噪音的降低、電池性能的改善、面罩佩戴舒適度的提高、濕化功能的增強以及遠程監測功能的改進，這些改進減少了治療中斷，並使臨床醫生能夠更早地發現患者病情的變化。

人工智慧對呼吸設備的累積影響

人工智慧 (AI) 透過改善個人化治療、分診、預測性維護和臨床決策支持，正在加速呼吸治療設備的演進。 AI 演算法可以支援正壓通氣 (PAP) 治療的自動調節，識別異常呼吸模式，發出面罩漏氣警報，並幫助臨床醫生解讀大量的用藥依從性和療效數據。在醫院和重症監護室，AI 驅動的呼吸監測結合檢驗的臨床工作流程和連續生命徵象數據，有助於及早發現病患病情惡化。

亞太地區、北美地區、歐洲地區、拉丁美洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區呼吸治療設備市場至關重要，這得益於其龐大的患者群體、嚴峻的都市區空氣品質挑戰、多個國家較高的吸煙率以及快速發展的醫院和居家照護基礎設施。中國、印度、日本、韓國、澳洲和東協等國家和地區的市場發展速度各不相同。成熟經濟體著重於互聯家庭照護和與老化相關的呼吸系統需求，而新興經濟體則更注重設備的可及性、可負擔性、氧氣供應和必要的呼吸支持。世界衛生組織（WHO）的證據表明，空氣污染和室內空氣污染與主要呼吸系統疾病的流行密切相關，由此引發的公眾健康問題，如空氣污染、結核病引起的肺部損傷、氣喘和慢性阻塞性肺病（COPD），持續影響全部區域的臨床需求。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東南亞國協，由於都市化進程加快、空氣污染加劇、中產階級醫療保健服務覆蓋範圍擴大以及各國致力於改善醫院和基層醫療服務，呼吸治療設備的重要性日益凸顯。該地區的優先事項包括價格合理的霧化器、氧氣療法、睡眠呼吸中止症的診斷以及高度擴充性的家庭呼吸護理，但跨境在報銷制度、臨床能力和監管成熟度方面的差異正在影響這些設備的普及應用。海灣合作理事會（GCC）地區以積極投資醫院基礎設施、數位醫療和專科醫療服務為特徵，這主要得益於肥胖相關睡眠呼吸障礙、氣喘和慢性呼吸系統疾病帶來的需求。在採購過程中，先進技術、服務品質和臨床培訓往往是重點關注的因素。

主要呼吸治療設備市場的關鍵國家特定趨勢

美國擁有完善的居家醫療服務、普及的睡眠醫學、強大的醫院重症監護能力以及整合的遠端患者監護，是治療性呼吸設備應用最先進的國家之一。在加拿大，公共醫療保健系統強調呼吸護理的可近性，重點關注家庭氧氣療法、睡眠呼吸中止症候群的治療以及在地域分散的人群中管理慢性疾病。在墨西哥，隨著私立醫院的蓬勃發展、公共部門的現代化以及臨床對氣喘、慢性阻塞性肺病和睡眠呼吸障礙日益成長的關注，呼吸設備的應用正在不斷擴大。同時，巴西大規模的醫療保健系統正透過公共和私人管道推動對氧氣療法、機械通氣、霧化治療和家庭呼吸護理服務的需求。

為呼吸治療設備行業的領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的創新技術，這些技術能夠在不增加使用者負擔的前提下，改善治療效果、提高遵從率和營運效率。人性化的設計至關重要。設備必須更安靜、更輕、更易於清潔和操作，同時還要滿足患者的多樣化需求，從新生兒和老年護理到慢性病自我管理。製造商應透過安全的遠端監控、可互通的資料交換、臨床醫生儀表板和病人參與工具來增強數位化能力，從而支持治療依從性，同時滿足使用者對隱私、網路安全和醫療設備軟體的期望。

調查方法

本執行摘要的調查方法是基於對可靠的二手資料、監管文件、臨床指南、公共衛生資料集、同行評審文獻以及與治療性呼吸設備相關的醫療保健政策資訊的三角檢驗。該分析考慮了呼吸系統疾病負擔、人口趨勢、醫療服務模式、設備監管、報銷環境、數位醫療應用以及各地區、國家和主要國家市場的基礎設施發展。

結論

治療性呼吸器處於慢性病管理、急性照護、居家醫療拓展和數位轉型交會點。呼吸系統疾病負擔日益加重、人口老化、環境風險因素、人們對睡眠呼吸障礙的認知不斷提高以及院外持續照護需求的增加，正在推動這一領域的變革。同時，人工智慧、遠端監測和互聯平台正在重新定義臨床醫生追蹤治療依從性、檢測風險和製定個人化治療方案的方式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 治療性呼吸設備市場：依設備類型分類

  • 正壓呼吸裝置（PAP）
  • 人工呼吸器
  • 氧氣療法設備
  • 噴霧器
  • 加濕器
  • 吸入器

第8章 治療性呼吸設備市場：依技術分類

  • 噴射霧化
  • 網狀霧化
  • 壓力控制式空氣供應
  • 超音波霧化

第9章 治療性呼吸設備市場：依模式分類

  • 侵襲型
  • 非侵入性

第10章 治療性呼吸設備市場：依患者類型分類

  • 成人
  • 老年人
  • 兒童

第11章 治療性呼吸設備市場：依便攜性分類

  • 可攜式的
  • 固定式

第12章 治療性呼吸設備市場：依應用領域分類

  • 慢性阻塞性肺病
  • 氣喘
  • 睡眠呼吸中止症
  • 急性呼吸窘迫症候群
  • 肺炎及呼吸道感染疾病
  • 囊腫纖維化
  • 神經肌肉疾病
  • 感染疾病後的呼吸治療

第13章 治療性呼吸設備市場：依最終用戶分類

  • 門診部
  • 緊急服務
  • 居家照護環境
    • 專業居家護理
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第14章 治療性呼吸設備市場：依通路分類

  • 離線
  • 線上

第15章 治療性呼吸設備市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第16章 治療性呼吸設備市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第17章 治療性呼吸設備市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第18章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Aeonmed Co., Ltd.
  • Air Liquide Healthcare
  • Apex Medical Corp.
  • Asahi Kasei Corporation
  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd.
  • CAIRE Inc.
  • Chart Industries, Inc.
  • Drive DeVilbiss Healthcare
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Corporation Limited
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hamilton Medical AG
  • ICU Medical, Inc.
  • Invacare Corporation
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Nidek Medical Products, Inc.
  • Nihon Kohden Corporation
  • O-Two Medical Technologies Inc.
  • Penlon Limited
  • ResMed Inc.
  • Smiths Medical, Inc.
  • SunMed LLC
  • Teleflex Incorporated
  • Vyaire Medical, Inc.
  • Weinmann Emergency Medical Technology GmbH+Co. KG
  • ZOLL Medical Corporation
Product Code: MRR-8C74ADFC179A

The Therapeutic Respiratory Devices Market is projected to grow by USD 38.03 billion at a CAGR of 5.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 26.29 billion
Estimated Year [2026] USD 27.62 billion
Forecast Year [2032] USD 38.03 billion
CAGR (%) 5.41%

Therapeutic respiratory devices are becoming central to modern care pathways as health systems respond to the sustained burden of chronic obstructive pulmonary disease (COPD), asthma, sleep-disordered breathing, neonatal respiratory distress, acute respiratory failure, and post-acute rehabilitation needs. The category includes oxygen therapy systems, nebulizers, positive airway pressure devices, ventilators, humidifiers, inhalation therapy equipment, airway clearance systems, and supporting interfaces used across hospitals, home care, emergency medicine, and long-term care settings. Demand is being shaped by aging populations, high exposure to air pollution and tobacco smoke in many regions, rising diagnosis of obstructive sleep apnea, and a broader shift toward home-based respiratory care.

The executive outlook for therapeutic respiratory devices is defined by three priorities: clinical effectiveness, care continuity, and safe usability. Hospitals continue to rely on advanced ventilatory support and high-acuity respiratory equipment, while home care adoption is expanding as patients, payers, and clinicians seek lower-burden management of chronic respiratory disease. Regulatory attention to device safety, cybersecurity, biocompatibility, performance testing, and post-market surveillance is intensifying, making evidence generation and quality systems essential differentiators. In this environment, manufacturers and healthcare providers are aligning device innovation with digital monitoring, patient adherence support, infection prevention, and interoperability with electronic health records and remote care platforms.

Transformative Shifts in the Therapeutic Respiratory Devices Landscape

The therapeutic respiratory devices landscape is undergoing a structural shift from episodic, facility-centered treatment toward connected, longitudinal respiratory care. Home oxygen therapy, continuous positive airway pressure therapy, portable nebulization, airway clearance, and non-invasive ventilation are increasingly integrated into chronic disease management programs. This transition is supported by improvements in device portability, quieter motors, battery performance, mask comfort, humidification, and remote monitoring features that help reduce treatment discontinuation and enable clinicians to identify changes in patient status earlier.

Another major transformation is the convergence of respiratory therapy with digital health. Devices are moving beyond mechanical support to become data-generating tools capable of tracking usage, pressure patterns, flow signals, leak rates, oxygen saturation integration, and therapy adherence. The shift is particularly important in sleep apnea management, COPD monitoring, and post-discharge respiratory support, where adherence and early intervention influence outcomes. At the same time, procurement teams are prioritizing resilient supply chains, reusable and single-patient-use infection-control components, standardized training protocols, and service continuity. Sustainability is also becoming more visible, with attention to energy efficiency, repairability, waste reduction, and responsible device disposal.

Cumulative Impact of Artificial Intelligence on Respiratory Devices

Artificial intelligence is accelerating the evolution of therapeutic respiratory devices by improving personalization, triage, predictive maintenance, and clinical decision support. AI-enabled algorithms can support automated titration in positive airway pressure therapy, identify abnormal breathing patterns, flag mask leakage, and help clinicians interpret high-volume adherence and performance data. In hospital and critical care settings, AI-assisted respiratory monitoring can contribute to earlier detection of patient deterioration when combined with validated clinical workflows and continuous vital-sign data.

The cumulative impact of AI is most evident in remote patient management. For chronic respiratory disease and sleep-disordered breathing, AI can help prioritize patients who require clinician outreach, detect therapy non-adherence, and support individualized coaching. In ventilatory support, AI-driven analytics may assist in recognizing patient-ventilator asynchrony, evaluating weaning readiness, and optimizing alarm management, provided the tools are clinically validated and used under professional oversight. However, AI adoption depends on transparent algorithms, representative training data, cybersecurity controls, regulatory compliance, and safeguards against overreliance. Industry leaders that combine AI with rigorous validation, human-centered design, and interoperable data architecture are better positioned to support safer respiratory care.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, the Middle East, and Africa

Asia-Pacific is a critical region for therapeutic respiratory devices because of its large patient base, urban air quality challenges, high smoking exposure in several countries, and rapidly expanding hospital and home care infrastructure. China, India, Japan, South Korea, Australia, and ASEAN markets are advancing at different speeds, with mature economies emphasizing connected home care and aging-related respiratory needs, while emerging economies focus on access, affordability, oxygen availability, and essential respiratory support. Public health attention to air pollution, tuberculosis-related lung damage, asthma, and COPD continues to influence clinical demand across the region, supported by World Health Organization evidence linking ambient and household air pollution to major respiratory morbidity.

North America remains highly advanced in respiratory therapy adoption, supported by established reimbursement pathways, sleep medicine networks, home healthcare providers, and strong critical care capacity. The United States and Canada show sustained use of positive airway pressure devices, oxygen concentrators, nebulizers, and advanced ventilatory systems, with increasing attention to remote patient monitoring, chronic care management, and value-based care. Latin America is shaped by uneven access across urban and rural settings, but Brazil and Mexico are strengthening respiratory care through expanding private healthcare, hospital modernization, oxygen system improvements, and greater recognition of sleep apnea, asthma, and chronic airway disease.

Europe demonstrates high regulatory rigor and broad clinical adoption across hospital and home settings, supported by aging demographics and national strategies addressing chronic respiratory disease, smoking cessation, and air quality. Germany, France, Italy, Spain, and the United Kingdom show strong demand for non-invasive ventilation, sleep therapy, and home oxygen services, while Eastern European systems continue to improve access and modernization. The Middle East is investing in hospital infrastructure, emergency care, and specialized respiratory services, particularly in Gulf economies where non-communicable diseases and sleep-disordered breathing are gaining clinical attention. Africa presents a highly diverse landscape, with urban tertiary centers using advanced respiratory equipment while many areas continue to face oxygen access, maintenance, training, and affordability constraints; initiatives to strengthen medical oxygen systems remain central to respiratory care resilience.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries are increasingly important in therapeutic respiratory devices due to rising urbanization, air pollution exposure, expanding middle-class healthcare utilization, and national efforts to improve hospital and primary care services. The region's priorities include affordable nebulizers, oxygen therapy, sleep apnea diagnosis, and scalable home respiratory care, while cross-border differences in reimbursement, clinical capacity, and regulatory maturity influence adoption. The GCC is characterized by strong investment in hospital infrastructure, digital health, and specialist services, with demand supported by obesity-associated sleep-disordered breathing, asthma, and chronic respiratory conditions; procurement often emphasizes advanced technology, service quality, and clinical training.

The European Union provides a mature regulatory and clinical environment for respiratory devices, with emphasis on safety, clinical evidence, post-market surveillance, interoperability, and patient-centered home care under stringent medical device rules. EU health systems increasingly connect respiratory therapy with chronic disease management, aging care, air quality policy, and sustainability objectives. BRICS countries represent a broad and heterogeneous opportunity landscape, combining large disease burdens, expanding healthcare access, domestic manufacturing ambitions, and cost-sensitive procurement. China and India are particularly influential due to scale and manufacturing capacity, while Brazil, Russia, and South Africa face distinct needs in hospital modernization, chronic respiratory management, oxygen availability, and equitable access.

G7 countries lead many clinical, regulatory, and digital adoption trends in therapeutic respiratory devices, especially in sleep therapy, non-invasive ventilation, remote monitoring, and high-acuity hospital care. Their aging populations and established reimbursement structures support long-term respiratory disease management, while regulatory expectations push manufacturers toward robust evidence and lifecycle safety controls. NATO member countries, although not a healthcare bloc, collectively influence procurement resilience, emergency preparedness, and medical device supply continuity, especially after recent global disruptions highlighted the strategic importance of ventilators, oxygen systems, consumables, and respiratory care logistics.

Key Country Insights Across Major Therapeutic Respiratory Device Markets

The United States is one of the most advanced therapeutic respiratory device environments, supported by extensive home healthcare services, sleep medicine adoption, hospital critical care capabilities, and remote patient monitoring integration. Canada emphasizes respiratory care access within publicly funded systems, with attention to home oxygen, sleep apnea treatment, and chronic disease management across geographically dispersed populations. Mexico is expanding respiratory device adoption through private hospital growth, public sector modernization, and rising clinical attention to asthma, COPD, and sleep-disordered breathing, while Brazil's large healthcare system drives demand for oxygen therapy, ventilatory support, nebulization, and home-based respiratory services across both public and private channels.

In Europe, the United Kingdom continues to prioritize respiratory disease management through primary care pathways, hospital services, smoking cessation initiatives, and home ventilation programs, while Germany benefits from strong medical technology adoption, specialist care networks, and established reimbursement for respiratory therapies. France demonstrates structured chronic disease management and home respiratory support, with attention to sleep apnea, COPD, and oxygen therapy. Russia's landscape is shaped by regional access variation, hospital modernization needs, and demand for essential and advanced respiratory support. Italy and Spain both show strong demand linked to aging populations, COPD prevalence, sleep therapy needs, and post-acute care pathways, with hospitals and home care providers playing important roles.

China is a major respiratory device market from a clinical and manufacturing perspective, influenced by large population scale, air pollution exposure, smoking-related disease, hospital expansion, and increasing diagnosis of sleep apnea and COPD. India combines a high respiratory disease burden with rising healthcare access, making affordability, durable design, oxygen availability, and service networks central to adoption. Japan's aging society supports advanced home respiratory care, oxygen therapy, and sleep-disordered breathing management, with high expectations for reliability and usability. Australia emphasizes evidence-based respiratory care, home oxygen, sleep therapy, and remote access solutions for dispersed populations, while South Korea combines strong digital health infrastructure, hospital sophistication, and growing adoption of connected respiratory technologies.

Actionable Recommendations for Therapeutic Respiratory Device Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves outcomes, adherence, and workflow efficiency without increasing user burden. Human-centered design is essential: devices should be quieter, lighter, easier to clean, simple to operate, and compatible with a range of patient needs, from neonatal and geriatric care to chronic disease self-management. Manufacturers should strengthen digital capabilities through secure remote monitoring, interoperable data exchange, clinician dashboards, and patient engagement tools that support adherence while meeting privacy, cybersecurity, and medical device software expectations.

Strategic execution should also focus on affordability and service resilience. In emerging and underserved markets, durable devices, local maintenance capacity, training programs, oxygen infrastructure support, and reliable consumable supply are as important as technical performance. In mature markets, differentiation should be built around evidence, usability, AI-enabled insights, and integration into home care and chronic disease management pathways. Organizations should invest in regulatory readiness, post-market surveillance, risk management, and quality documentation early in development. Partnerships with healthcare providers, home care organizations, payers, and public health agencies can improve adoption by aligning devices with real-world respiratory care delivery.

Research Methodology

The research methodology for this executive summary is based on triangulation of credible secondary sources, regulatory references, clinical guidelines, public health datasets, peer-reviewed literature, and healthcare policy information relevant to therapeutic respiratory devices. The analysis considers respiratory disease burden, demographic trends, care delivery models, device regulation, reimbursement context, digital health adoption, and infrastructure readiness across regions, country groups, and major national markets.

Insights are synthesized through a qualitative assessment of verified indicators rather than market sizing or forecasting. The approach emphasizes disease epidemiology from recognized public health sources, regulatory and standards-based evidence, hospital and home care adoption patterns, technology trends, and region-specific healthcare system characteristics. Particular attention is given to COPD, asthma, sleep apnea, oxygen therapy access, non-invasive ventilation, critical care capacity, AI-enabled monitoring, and post-market device safety. This methodology supports a balanced, data-backed view of opportunities, constraints, and strategic priorities without relying on speculative commercial projections.

Conclusion

Therapeutic respiratory devices are at the intersection of chronic disease management, acute care readiness, home healthcare expansion, and digital transformation. The sector is being reshaped by the rising burden of respiratory disorders, aging populations, environmental risk factors, sleep-disordered breathing awareness, and the need for continuous care beyond hospital walls. At the same time, AI, remote monitoring, and connected platforms are redefining how clinicians track adherence, detect risk, and personalize therapy.

Regional and country-level differences remain significant. Mature health systems are advancing connected respiratory care, evidence-based procurement, and home therapy integration, while emerging markets are focused on affordability, oxygen access, infrastructure, and workforce training. The strongest strategies will combine validated technology, regulatory discipline, inclusive design, secure data systems, and reliable service models. Organizations that align respiratory device innovation with measurable clinical value, patient usability, and resilient care delivery will be best positioned to support the next phase of respiratory healthcare transformation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Therapeutic Respiratory Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Positive Airway Pressure (PAP) Devices
  • 7.3. Ventilators
  • 7.4. Oxygen Therapy Devices
  • 7.5. Nebulizers
  • 7.6. Humidifiers
  • 7.7. Inhalers

8. Therapeutic Respiratory Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Jet Nebulization
  • 8.3. Mesh Nebulization
  • 8.4. Pressure Controlled Delivery
  • 8.5. Ultrasonic Nebulization

9. Therapeutic Respiratory Devices Market, by Mode

  • 9.1. Introduction
  • 9.2. Invasive
  • 9.3. Noninvasive

10. Therapeutic Respiratory Devices Market, by Patient Type

  • 10.1. Introduction
  • 10.2. Adult
  • 10.3. Geriatric
  • 10.4. Pediatric

11. Therapeutic Respiratory Devices Market, by Portability

  • 11.1. Introduction
  • 11.2. Portable
  • 11.3. Stationary

12. Therapeutic Respiratory Devices Market, by Application

  • 12.1. Introduction
  • 12.2. Chronic Obstructive Pulmonary Disease
  • 12.3. Asthma
  • 12.4. Sleep Apnea
  • 12.5. Acute Respiratory Distress Syndrome
  • 12.6. Pneumonia & Respiratory Infections
  • 12.7. Cystic Fibrosis
  • 12.8. Neuromuscular Disorders
  • 12.9. Post-COVID Respiratory Therapy

13. Therapeutic Respiratory Devices Market, by End User

  • 13.1. Introduction
  • 13.2. Ambulatory Care Centers
  • 13.3. Emergency Services
  • 13.4. Homecare Settings
    • 13.4.1. Professional Homecare
    • 13.4.2. Self Administration
  • 13.5. Hospitals
    • 13.5.1. Private Hospitals
    • 13.5.2. Public Hospitals

14. Therapeutic Respiratory Devices Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Offline
  • 14.3. Online

15. Therapeutic Respiratory Devices Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. Europe
  • 15.3. North America
  • 15.4. Latin America
  • 15.5. Africa
  • 15.6. Middle East

16. Therapeutic Respiratory Devices Market, by Group

  • 16.1. NATO
  • 16.2. G7
  • 16.3. BRICS
  • 16.4. European Union
  • 16.5. ASEAN
  • 16.6. GCC

17. Therapeutic Respiratory Devices Market, by Country

  • 17.1. China
  • 17.2. United States
  • 17.3. Japan
  • 17.4. India
  • 17.5. Germany
  • 17.6. United Kingdom
  • 17.7. Australia
  • 17.8. France
  • 17.9. South Korea
  • 17.10. Italy
  • 17.11. Canada
  • 17.12. Russia
  • 17.13. Brazil
  • 17.14. Mexico
  • 17.15. Spain

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2025
  • 18.2. FPNV Positioning Matrix, 2025
  • 18.3. Market Concentration Analysis, 2025
    • 18.3.1. Concentration Ratio (CR)
    • 18.3.2. Herfindahl Hirschman Index (HHI)
  • 18.4. Recent Developments & Impact Analysis, 2025
  • 18.5. Product Portfolio Analysis, 2025
  • 18.6. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Aeonmed Co., Ltd.
  • 19.2. Air Liquide Healthcare
  • 19.3. Apex Medical Corp.
  • 19.4. Asahi Kasei Corporation
  • 19.5. Becton, Dickinson and Company
  • 19.6. BMC Medical Co., Ltd.
  • 19.7. CAIRE Inc.
  • 19.8. Chart Industries, Inc.
  • 19.9. Drive DeVilbiss Healthcare
  • 19.10. Dragerwerk AG & Co. KGaA
  • 19.11. Fisher & Paykel Healthcare Corporation Limited
  • 19.12. GE HealthCare Technologies Inc.
  • 19.13. Getinge AB
  • 19.14. Hamilton Medical AG
  • 19.15. ICU Medical, Inc.
  • 19.16. Invacare Corporation
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Masimo Corporation
  • 19.19. Medtronic plc
  • 19.20. Nidek Medical Products, Inc.
  • 19.21. Nihon Kohden Corporation
  • 19.22. O-Two Medical Technologies Inc.
  • 19.23. Penlon Limited
  • 19.24. ResMed Inc.
  • 19.25. Smiths Medical, Inc.
  • 19.26. SunMed LLC
  • 19.27. Teleflex Incorporated
  • 19.28. Vyaire Medical, Inc.
  • 19.29. Weinmann Emergency Medical Technology GmbH + Co. KG
  • 19.30. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 29. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VENTILATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VENTILATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENTILATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HUMIDIFIERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HUMIDIFIERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HUMIDIFIERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INHALERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INHALERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INHALERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JET NEBULIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JET NEBULIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JET NEBULIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MESH NEBULIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MESH NEBULIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MESH NEBULIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PRESSURE CONTROLLED DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PRESSURE CONTROLLED DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PRESSURE CONTROLLED DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASONIC NEBULIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASONIC NEBULIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASONIC NEBULIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NONINVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NONINVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NONINVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ASTHMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ASTHMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ASTHMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SLEEP APNEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SLEEP APNEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SLEEP APNEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PNEUMONIA & RESPIRATORY INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PNEUMONIA & RESPIRATORY INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PNEUMONIA & RESPIRATORY INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROMUSCULAR DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROMUSCULAR DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROMUSCULAR DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POST-COVID RESPIRATORY THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POST-COVID RESPIRATORY THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POST-COVID RESPIRATORY THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EMERGENCY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EMERGENCY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EMERGENCY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PROFESSIONAL HOMECARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PROFESSIONAL HOMECARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PROFESSIONAL HOMECARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SELF ADMINISTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SELF ADMINISTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SELF ADMINISTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 245. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 279. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 282. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. JAPAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 299. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 321. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 323. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE THERAPEUTIC RESPIRATORY DEVICES MARKET S